Isoform-specific regulation of adenylyl cyclase by oxidized catecholamines

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 4, 1997, Pages 1247-1254

  Ebina, Toshiaki ^a   Toya, Yoshiyuki ^a   Oka, Naoki ^a   Schwencke, Carsten ^a   Kawabe, Jun Ichi ^a   Ishikawa, Yoshihiro ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adenylyl cyclase; Catecholamine; Isoforms; Manganese; Oxidation

Indexed keywords

ADENYLATE CYCLASE; ADRENALIN; ADRENOCHROME; CATECHOLAMINE DERIVATIVE; DOPAMINE; ISOPRENALINE; MANGANESE;

ANIMAL CELL; ARTICLE; ENZYME INHIBITION; ENZYME KINETICS; ENZYME REGULATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0031128197     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0362     Document Type: Article

References (32)

1. ARCHIBALD FS, TYREE C, 1987. Manganese poisoning and the attack of trivalent manganese upon catecholamines. Arch Biochem Biophys 256: 638-650.
2. BEAMISH RE, DHILLON KS, SINGAL PK, DHALLA NS, 1981. Protective effect of sulfinpyrazone against catecholamine metabolite adrenochrome-induced arrhythmias. Am Heart J 102: 149-152.
3. BENDER JL, EVA NJ, 1983. Properties of the adenylate cyclase catalytic unit from caudate nucleus. J Biol Chem 258: 2432-2439.
4. BINDOLI A, RIGOBELLO MP, GLAZIGNA L, 1989. Toxicity of aminochromes. Toxicol Lett 48: 2-20.
5. DAVIES KJA, 1991. Oxidative damage and repair: chemical, biological and medical aspects. New York: Pergamon Press.
6. DHALLA KS, GANGULY PK, RUPP H, BEAMISH RE, DHALLA NS, 1989. Measurement of adrenolutin as an oxidation product of catecholamines in plasma. Mol Cell Biochem 87: 85-92.
7. DHALLA NS, YATES JC, NAIMARK B, DHALLA KS, BEAMISH RE, OSTADAL B, 1992. Cardiotoxicity of catecholamines and related agents. In: Acosta D Jr (ed.). Cardiovascular Toxicology. New York: Raven Press, Ltd, 239-282.
8. ERAUSQUIN GAD, COSTA E, HANBAUER I, 1994. Calcium homeostasis, free radical formation, and trophic factor dependence mechanisms in Parkinson's disease. Pharmacol Rev 46: 467-482.
9. 2+/calmodulin-insensitive adenylyl cyclase from rat brain. Proc Natl Acad Sci USA 88: 10173-10177.
10. GILMAN AG, 1987. G proteins: transducers of receptor-generated signals. Ann Rev Biochem 56: 615-649.
11. GOLDSTEIN DS, 1995. Stress, catecholamines and cardiovascular disease. Oxford: Oxford University Press.
12. GREEN S, MAZUR A, SHORR E, 1956. Mechanism of the catalytic oxidation of adrenaline by ferritin. J Biol Chem 220: 237-255.
13. HAMMOND B, HESS ML, 1985. The oxygen free radical system: potential mediator of myocardial injury. JACC 6: 215-220.
14. HARPER JF, 1986. Desensitization in rat parotid to β-adrenergic agonists and counteracting effects of forskolin are conserved in membrane and detergent-solubilized adenylate cyclase catalyst activity. J Cycl Nucl Protein Phos Res 11: 167-176.
15. HARRISON WH, WHISLER WW, HILL BJ, 1968. Catecholamine oxidation and ionization properties indicated from the H release, tritium exchange, and spectral changes which occur during ferricyanide oxidation. Biochemistry 7: 3089-3094.
16. ISHIKAWA Y, SOROTA S, KIUCHI K, SHANNON RP, KOMAMURA K, KATSUSHIKA S, VATNER DE, VATNER SF, HOMCY CJ, 1994. Down-regulation of adenylylcyclase types V and VI mRNA levels in pacing-induced heart failure. J Clin Invest 93: 2224-2229.
17. IYENGAR R, 1993. Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases. FASEB J 7: 768-775.
18. JENNER P, 1994. Oxidative damage in neurodegenerative disease. Lancet 344: 796-798.
19. JONES TL, WOODARD C AND SPIEGEL AM, 1993. Baculovirus expression and purification of a soluble, mutant G-protein alpha subunit. Protein Expr Purif 4: 64-71.
20. KANTOS HA, WEI EP, POVLISHOCK JT, CHRISTMAN CW, 1984. Oxygen radicals mediate the cerebral arteriolar dilation from arachidonate and bradykinin in cats. Circ Res 55: 293-303.
21. KAWABE J, EBINA T, ISMAIL S, KITCHEN D, HOMCY CJ, ISHIKAWA Y, 1994. A novel peptide inhibitor of adenylyl cyclase (AC): a peptide from type V AC directly inhibits AC catalytic activity. J Biol Chem 269: 24906-24911.
22. LIMBIRD LE, HICKEY AR, LEFKOWITZ RL, 1979. Unique uncoupling of the frog erythrocyte adenylate cyclase system by manganese. J Biol Chem 254: 2677-2683.
23. LIMBIRD LE, MACMILLAN ST, 1981. Mn-uncoupling of the catecholamine sensitive adenylate cyclase system of rat reticulocytes. Biochem Biophys Acta 677: 408-416.
24. MITTAG TW, TORMAY A, PODOS SM, 1988. Manganous chloride stimulation of adenylate cyclase responsiveness in ocular ciliary process membranes. Exp Eye Res 46: 841-851.
25. Ross EM, GILMAN AG, 1980. Biochemical properties of hormone sensitive adenylate cyclase. Annu Rev Biochem 49: 533-564.
26. SINGAL PK, DHILLON KS, BEAMISH RE, KAPUR N, DHALLA NS, 1982. Myocardial cell damage and cardiovascular changes due to infusion of adrenochrome in rats. Br J Exp Path 63: 167-176.
27. STEINBERG SF, CHOW YK, BILEZIKIAN JP, 1986. Regulation of rat heart membrane adenylate cyclase by magnesium and manganese. J Pharmacol Exp Ther 237: 764-772.
28. TAAM GML, TAKEO S, ZIEGELHOFFER A, SINGAL PK, BEAMISH RE, DHALLA NS, 1986. Effect of adrenochrome on adenine nucleotides and mitochondrial oxidative phosphorylation in rat heart. Can J Cardiol 2: 88-93.
29. TAKEO S, TAAM GML, BEAMISH RE, DHALLA NS, 1980. Effects of adrenochrome on calcium accumulation and adenosine triphosphatase activity of the rat heart microsome. J Pharmacol Exp Ther 214: 688-693.
30. WOLIN MS, BELLONI FL, 1985. Superoxide anion selectively attenuates catecholamine-induced contractile tension in isolated rabbit aorta. Am J Physiol 246: H1127-H1133.
31. WONG A, HWANG SM, CHENG HY AND CROOKE ST, 1989. Structure-activity relationships of β-adrenergic receptor-coupled adenylate cyclase: Implications of a redox mechanism for the action of agonist at β-adrenergic receptors. Mol Pharmacol 31: 368-376.
32. YATES JC, BEAMISH RE, DHALLA NS, 1981. Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: Relation to pathogenesis of catecholamine cardiomyopathy. Am Heart J 102: 210-221.